Repositorio Dspace

Listar por autor "Gajate, Pablo"

Listar por autor "Gajate, Pablo"

Ordenar por:Orden:Resultados:

  • Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study 
    Mitjavila, Mercedes; Jiménez-Fonseca, Paula; Bello, Pilar; Pubul, Virginia; Percovich, Juan-Carlos; García-Burillo, Amparo; Hernando, Jorge; Arbizu, Javier; Rodeno, Emilia; Estorch, Montserrat; Llana, Belén; Castellon, Maribel; García-Canamaque, Lina; Gajate, Pablo; Riesco, María-Carmen; Miguel, María-Begoña; Balaguer-Muñoz, David; Custodio, Ana-Belén; Cano, Juana-María; Repetto, Alexandra; García-Alfonso, Pilar; Muros, María-Angustias; Vercher-Conejero, José-Luis; Carmona-Bayonas, Alberto (Springer, 2023-07)
    BACKGROUND: Peptide receptor radionuclide therapy (PRRT) is one of the most promising therapeutic strategies in neuroendocrine neoplasms (NENs). Nevertheless, its role in certain tumor sites remains unclear. This study ...
  • Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study 
    Fernández, Ovidio; Molina, Aurea; Anido-Herranz, Urbano; Álvarez, Carlos; Girones, Regina; Gajate, Pablo; García-Domínguez, Rocio; Ros-Martínez, Silverio; Puente, Javier; Blasco, Sara; Ore-Arce, Martin; Noguerón-Martínez, Esther; Fernández-Freire, Ana; del-Pozo, Nieves; Cassinello, Javier; Lazaro-Quintela, Martin; Arranz, Fernando; Crespo, Guillermo; Abad, María-Teresa; Llorente, Mar; Sánchez-Hernández, Alfredo; Juan, María-José (SPRINGER INT PUBL AG, 2025-07-09)
    PURPOSE: Maintenance avelumab has shown improved overall survival compared to chemotherapy alone in first-line treatment of advanced urothelial carcinoma. This study evaluates real-world evidence of avelumab as first-line ...
  • Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study 
    Fernández, Ovidio; Molina, Aurea; Anido-Herranz, Urbano; Álvarez, Carlos; Girones, Regina; Gajate, Pablo; García-Domínguez, Rocío; Ros-Martínez, Silverio; Puente, Javier; Blasco, Sara; Ore-Arce, Martín; Noguerón-Martínez, Esther; Fernández-Freire, Ana; del-Pozo, Nieves; Cassinello, Javier; Lazaro-Quintela, Martín; Arranz, Fernando; Crespo, Guillermo; Abad, María-Teresa; Llorente, Mar; Sánchez-Hernández, Alfredo; Juan, María-José (SPRINGER INT PUBL AG, 2025-07-09)
    PURPOSE: Maintenance avelumab has shown improved overall survival compared to chemotherapy alone in first-line treatment of advanced urothelial carcinoma. This study evaluates real-world evidence of avelumab as first-line ...